TroVax News
Most Popular TroVax Story
Is Sanofi preparing a bid for Oxford BioMedica?
Investors have focused their attention on Oxford BioMedica, a struggling UK developer that is the Read more...
Latest Headlines
- October 7, 2008
- September 4, 2008
- August 15, 2008
- February 12, 2008
- September 11, 2007
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
